209 related articles for article (PubMed ID: 35769688)
1. The Efficacy of Japanese Herbal Kampo Medicine as an Acute and Prophylactic Medication to Treat Chronic Daily Headache and Medication Overuse Headache:-Single Arm Retrospective Study.
Katsuki M; Kashiwagi K; Kawamura S; Koh A
Cureus; 2022 May; 14(5):e25419. PubMed ID: 35769688
[TBL] [Abstract][Full Text] [Related]
2. Medication Overuse Headache Successfully Treated by Three Types of Japanese Herbal Kampo Medicine.
Katsuki M; Kawamura S; Kashiwagi K; Koh A
Cureus; 2021 Jul; 13(7):e16800. PubMed ID: 34513406
[TBL] [Abstract][Full Text] [Related]
3. Medication Overuse Headache Successfully Treated by Japanese Herbal Kampo Medicine, Yokukansan.
Katsuki M; Kawamura S; Kashiwagi K; Koh A
Cureus; 2021 Sep; 13(9):e18326. PubMed ID: 34725590
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Kampo medicine Kakkonto as acute medication to treat tension-type headache among musculoskeletal pain patients using regular analgesics.
Katsuki M; Matsumori Y; Kashiwagi K; Kawamura S; Koh A
Rinsho Shinkeigaku; 2023 Feb; 63(2):73-77. PubMed ID: 36725011
[TBL] [Abstract][Full Text] [Related]
5. Oxybutynin for Primary Palmer Hyperhidrosis Attenuates Migraine Attacks and Burdens.
Katsuki M
Cureus; 2023 Sep; 15(9):e44826. PubMed ID: 37818504
[TBL] [Abstract][Full Text] [Related]
6. Chronic Daily Headache and Medication Overuse Headache in First-Visit Headache Patients in Korea: A Multicenter Clinic-Based Study.
Cha MJ; Moon HS; Sohn JH; Kim BS; Song TJ; Kim JM; Park JW; Park KY; Kim SK; Kim BK; Cho SJ
J Clin Neurol; 2016 Jul; 12(3):316-22. PubMed ID: 27449912
[TBL] [Abstract][Full Text] [Related]
7. Update on chronic daily headache.
Couch JR
Curr Treat Options Neurol; 2011 Feb; 13(1):41-55. PubMed ID: 21103961
[TBL] [Abstract][Full Text] [Related]
8. Questionnaire-Based Survey during COVID-19 Vaccination on the Prevalence of Elderly's Migraine, Chronic Daily Headache, and Medication-Overuse Headache in One Japanese City-Itoigawa Hisui Study.
Katsuki M; Kawahara J; Matsumori Y; Yamagishi C; Koh A; Kawamura S; Kashiwagi K; Kito T; Entani A; Yamamoto T; Otake M; Ikeda T; Yamagishi F
J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012946
[TBL] [Abstract][Full Text] [Related]
9. Prevention of medication overuse and medication overuse headache in patients with migraine: a randomized, controlled, parallel, allocation-blinded, multicenter, prospective trial using a mobile software application.
Diener HC; Donoghue S; Gaul C; Holle-Lee D; Jöckel KH; Mian A; Schröder B; Kühl T
Trials; 2022 May; 23(1):382. PubMed ID: 35546412
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal Antibodies Against the Calcitonin Gene-Related Peptide and Its Receptor in Japanese Adolescents With Migraines.
Katsuki M; Kashiwagi K; Kawamura S; Koh A
Cureus; 2023 Jan; 15(1):e33689. PubMed ID: 36788886
[TBL] [Abstract][Full Text] [Related]
11. Erenumab in highly therapy-refractory migraine patients: First German real-world evidence.
Scheffler A; Messel O; Wurthmann S; Nsaka M; Kleinschnitz C; Glas M; Naegel S; Holle D
J Headache Pain; 2020 Jul; 21(1):84. PubMed ID: 32620151
[TBL] [Abstract][Full Text] [Related]
12. Fremanezumab for Migraine Prevention in Japanese Elderly Aged Over 70 Years Old.
Katsuki M; Kashiwagi K; Kawamura S; Tachikawa S; Koh A
Cureus; 2023 Jan; 15(1):e34052. PubMed ID: 36824556
[TBL] [Abstract][Full Text] [Related]
13. The First Case Series From Japan of Primary Headache Patients Treated by Completely Online Telemedicine.
Katsuki M
Cureus; 2022 Nov; 14(11):e31068. PubMed ID: 36475218
[TBL] [Abstract][Full Text] [Related]
14. Effects of electroacupuncture on treatment-resistant chronic migraine with medication overuse headache: A 12-month follow-up case report.
Gao N; Wu L; Liu X; Lin Z; Liu Z; Liang J; Wang W
Heliyon; 2024 May; 10(9):e30417. PubMed ID: 38720738
[TBL] [Abstract][Full Text] [Related]
15. Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new appendix criteria.
Zeeberg P; Olesen J; Jensen R
Cephalalgia; 2009 Feb; 29(2):214-20. PubMed ID: 18823364
[TBL] [Abstract][Full Text] [Related]
16. [Management of chronic daily headache in children and adolescents].
Cuvellier JC
Rev Neurol (Paris); 2009; 165(6-7):521-31. PubMed ID: 19041108
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
[TBL] [Abstract][Full Text] [Related]
18. Single-Pulse Transcranial Magnetic Stimulation for the preventive treatment of difficult-to-treat migraine: a 12-month prospective analysis.
Lloyd JO; Hill B; Murphy M; Al-Kaisy A; Andreou AP; Lambru G
J Headache Pain; 2022 Jun; 23(1):63. PubMed ID: 35668368
[TBL] [Abstract][Full Text] [Related]
19. Burden of Episodic Migraine, Chronic Migraine, and Medication Overuse Headache in Alberta.
McMullen S; Graves E; Ekwaru P; Pham T; Mayer M; Ladouceur MP; Hubert M; Bougie J; Amoozegar F
Can J Neurol Sci; 2023 Oct; ():1-11. PubMed ID: 37795668
[TBL] [Abstract][Full Text] [Related]
20. Chronic daily headache in adolescents: prevalence, impact, and medication overuse.
Wang SJ; Fuh JL; Lu SR; Juang KD
Neurology; 2006 Jan; 66(2):193-7. PubMed ID: 16434652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
